An Australian stem cell and regenerative medicine company

July 27, 2023

Investor Webinar Presentation

Listen to Cynata’s CEO and MD, Dr Kilian Kelly, provide an overview of the recently completed strategic review, and responses to investors’ questions.


Listen Here

July 26, 2023

Dr Kilian Kelly interviewed by Proactive Investors following strategic review

Following the completion of a strategic review of Cynata’s clinical development portfolio, CEO Dr Kilian Kelly sat down with Proactive Investors to discuss the review and his direction for the Company. Watch the interview here.

Or read more about it on the Cairns Post here.

July 25, 2023

Cynata provides Ausbiz’s Small Caps a clinical trials update

Having recently completed a strategic review of its clinical development portfolio under the new leadership of Dr Kilian Kelly, CEO & Managing Director, he outlines to Ausbiz what investors can expect from the Cynata in the near and long-term. Watch the interview here (start at 18.37)

July 24, 2023

Dr Boreham’s Crucible

Following the change in leadership from Dr Ross Macdonald to Dr Kilian Kelly, Stockhead’s Tim Boreham examined Cynata in detail (though a mere days before the strategic review) 

Read the analysis here. 

June 30, 2023

Dr Ross Macdonald retires, Dr Kilian Kelly announced as new CEO

Dr Ross Macdonald announces his retirement, with Cynata appointing Chief Commercial Officer Dr Killian Kelly to the role of CEO and Managing Director, effective 1 July 2023. In addition, Dr David Atkins will join Cynata’s board, with Dr Stewart Washer stepping down from his position as a non-executive director.

Learn more on The Market Herald here.